|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 63 | 2016 | Statistical evaluation of surrogate endpoints with examples from cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 64 | 2016 | Neoadjuvant as Future for Drug Development in Breast Cancer-Letter | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A1 |
| 65 | 2016 | The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials | Peron, Julien; Roy, Pascal; Ozenne, Brice; Roche, Laurent; BUYSE, Marc | Journal Contribution | A1 |
| 66 | 2016 | Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren' | Saad, E. D.; BUYSE, Marc | Journal Contribution | A1 |
| 67 | 2016 | Adaptive Randomization of Neratinib in Early Breast Cancer | BUYSE, Marc; Saad, E.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 68 | 2016 | An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal Inference | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 69 | 2016 | Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents | Saad, E. D.; BUYSE, Marc | Journal Contribution | A1 |
| 70 | 2016 | Neratinib after trastuzumab in patients with HER2-positive breast cancer Reply | Chan, Arlene; BUYSE, Marc; Yao, Bin | Journal Contribution | A1 |
| 71 | 2015 | Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid Leukemia | Schlenk, Richard F.; Doehner, Hartmut; Doehner, Konstanze; Ganser, Arnold; Heuser, Michael; Benner, Axel; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 72 | 2015 | Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer | Ciani, Oriana; BUYSE, Marc; Garside, Ruth; Peters, Jaime; Saad, Everardo D.; Stein, Ken; Taylor, Rod S. | Journal Contribution | A1 |
| 73 | 2015 | On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 74 | 2015 | Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers | Zhao, Lili; Feng, Dai; Neelon, Brian; BUYSE, Marc | Journal Contribution | A1 |
| 75 | 2015 | Biomarker‑based surrogate endpoints | BUYSE, Marc; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Book Section | B2 |
| 76 | 2014 | Implementation Issues in Adaptive Design Trials | Danielson, Linda; Carlier, Jerome; BURZYKOWSKI, Tomasz; BUYSE, Marc | Book Section | B2 |
| 77 | 2014 | Data Sharing, Year 1 - Access to Data from Industry-Sponsored Clinical Trials | Strom, Brian L.; BUYSE, Marc; Hughes, John; Knoppers, Bartha M. | Journal Contribution | A2 |
| 78 | 2014 | Linear mixed-effects models for central statistical monitoring of multicenter clinical trials | Desmet, L.; Venet, D.; Doffagne, E.; Timmermans, C.; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, Marc | Journal Contribution | A1 |
| 79 | 2013 | Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used? | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 80 | 2013 | Professor Maurice Staquet, MD, MS (1930-2013) In Memoriam | Duez, Nicole; Eeckhoudt, Dominique; Kirkpatrick, Anne; Solbu, Gabriel; Suciu, Stefan; SYLVESTER, Richard; Van Glabbeke, Martine; BUYSE, Marc; Dalesio, Otilia; Renard, Josette; Rotmensz, Nicole | Journal Contribution | M |
| 81 | 2013 | Statistical evaluation of surrogate endpoints in clinical studies | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, Marc | Book Section | B2 |
| 82 | 2013 | Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis | Oba, Koji; PAOLETTI, Xavier; Bang, Yung-Jue; Bleiberg, Harry; BURZYKOWSKI, Tomasz; Fuse, Nozomu; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-Pierre; Rougier, Philippe; Pompidou, Georges; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Shitara, Kohei; Tsuburaya, Akira; Van Cutsem, Eric; BUYSE, Marc | Journal Contribution | A1 |
| 83 | 2013 | Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials | Laporte, Silvy; Squifflet, Pierre; Baroux, Noemie; Fossella, Frank; Georgoulias, Vassilis; Pujol, Jean-Louis; Douillard, Jean-Yves; Kudoh, Shinzohy; Pignon, Jean-Pierre; Quinaux, Emmanuel; BUYSE, Marc | Journal Contribution | A1 |
| 84 | 2013 | Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis | Oba, Koji; PAOLETTI, Xavier; Alberts, Steven; Bang, Yung-Jue; Benedetti, Jacqueline; Bleiberg, Harry; CATALANO, Paul; Lordick, Florian; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-pierre; Rougier, Philippe; Sasako, Mitsuru; Sakamoto, Junichi; Sargent, Daniel; Shitara, Kohei; Cutsem, Eric Van; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 85 | 2013 | Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis | PAOLETTI, Xavier; Oba, Koji; Bang, Yung-Jue; Bleiberg, Harry; Boku, Narikazu; Bouche, Olivier; Fuse, Nozomu; Michiels, Stefan; Moehler, Markus; Morita, Satoshi; Ohashi, Yasuo; Ohtsu, Atsushi; Roth, Arnaud; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Shitara, Kohei; Thuss-Patience, Peter; Van Cutsem, Eric; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 86 | 2013 | Omics-based clinical trial designs | BUYSE, Marc; Michiels, Stefan | Journal Contribution | A1 |
| 87 | 2013 | Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study | Ciani, Oriana; BUYSE, Marc; Garside, Ruth; Pavey, Toby; Stein, Ken; Sterne, Jonathan A. C.; Taylor, Rod S. | Journal Contribution | A1 |
| 88 | 2012 | A statistical approach to central monitoring of data quality in clinical trials | Venet, David; Doffagne, Erik; BURZYKOWSKI, Tomasz; Beckers, Francois; Tellier, Yves; Genevois-Marlin, Eric; Becker, Ursula; Bee, Valerie; Wilson, Veronique; LEGRAND, Catherine; BUYSE, Marc | Journal Contribution | A1 |
| 89 | 2012 | Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time | Baker, Stuart G.; Sargent, Daniel J.; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 90 | 2011 | Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia | BUYSE, Marc; Squifflet, Pierre; Lange, Beverly J.; Alonzo, Todd A.; Larson, Richard A.; Kolitz, Jonathan E.; George, Stephen L.; Bloomfield, Clara D.; Castaigne, Sylvie; Chevret, Sylvie; Blaise, Didier; Maraninchi, Dominique; Lucchesi, Kathryn J.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 91 | 2011 | Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials | Shi, Qian; Renfro, Lindsay A.; Bot, Brian M.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sargent, Daniel J. | Journal Contribution | A1 |
| 92 | 2011 | Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens | Valero, Vicente; Forbes, John; Pegram, Mark D.; Pienkowski, Tadeusz; Eiermann, Wolfgang; von Minckwitz, Gunter; Roche, Henri; Martin, Miguel; Crown, John; Mackey, John R.; Fumoleau, Pierre; Rolski, Janusz; Mrsic-Krmpotic, Zrinka; Jagiello-Gruszfeld, Agnieszka; Riva, Alessandro; BUYSE, Marc; Taupin, Henry; Sauter, Guido; Press, Michael F.; Slamon, Dennis J. | Journal Contribution | A1 |
| 93 | 2011 | Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission | BUYSE, Marc; Michiels, Stefan; Squifflet, Pierre; Lucchesi, Kathryn J.; Hellstrand, Kristoffer; Brune, Mats L.; Castaigne, Sylvie; Rowe, Jacob M. | Journal Contribution | A1 |
| 94 | 2011 | Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer | Gill, S.; Berry, S.; Biagi, J.; Butts, C.; BUYSE, Marc; Chen, E.; Jonker, D.; Marginean, C.; Samson, B.; Stewart, J.; Thirlwell, M.; Wong, R.; Maroun, J. A. | Journal Contribution | A1 |
| 95 | 2011 | Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia | BUYSE, Marc; Squifflet, Pierre; Lucchesi, Kathryn J.; Brune, Mats L.; Castaigne, Sylvie; Rowe, Jacob M. | Journal Contribution | A1 |
| 96 | 2010 | Generalized pairwise comparisons of prioritized outcomes in the two-sample problem | BUYSE, Marc | Journal Contribution | A1 |
| 97 | 2010 | A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; Tilahun, Abel; BUYSE, Marc | Journal Contribution | A1 |
| 98 | 2010 | Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis | PAOLETTI, Xavier; Oba, Koji; BURZYKOWSKI, Tomasz; Michiels, Stefan; Ohashi, Yasuo; Pignon, Jean-Pierre; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Van Cutsem, Eric; BUYSE, Marc | Journal Contribution | A1 |
| 99 | 2010 | The correlation structure of longitudinal measurements of vision in patients with macular degeneration. | BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 100 | 2009 | Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial) | Piessevaux, H.; BUYSE, Marc; De Roock, W.; Prenen, H.; Schlichting, M.; Van Cutsem, E.; Tejpar, S. | Journal Contribution | A1 |
| 101 | 2009 | Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer | BUYSE, Marc | Journal Contribution | A1 |
| 102 | 2009 | Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data | Michiels, Stefan; Le Maitre, Aurelie; BUYSE, Marc; BURZYKOWSKI, Tomasz; Maillard, Emilie; Bogaerts, Jan; Vermorken, Jan B.; Budach, Wilfried; Pajak, Thomas F.; Ang, Kian K.; Bourhis, Jean; Pignon, Jean-Pierre | Journal Contribution | A1 |
| 103 | 2009 | Use of Meta-Analysis for the Validation of Surrogate Endpoints and Biomarkers in Cancer Trials | BUYSE, Marc | Journal Contribution | A1 |
| 104 | 2008 | European regulatory agencies should employ full time statisticians | Hughes, Sara; Keene, Oliver; Howitt, Nigel; Roes, Kit; Ashby, Deborah; Beltangady, Mohan; Bird, Sheila M.; Burton, Catherine; BUYSE, Marc; Day, Simon; van Ewijk, Peter; Fletcher, Chrissie; Grieve, Andrew P.; Guinot, Christiane; Hand, David J.; Hemmings, Rob; Holt, D.; Hothorn, Ludwig; Jagers, Peter; Keiding, Niels; Korhonen, Pasi; LESAFFRE, Emmanuel; Lewis, John A.; MOLENBERGHS, Geert; Neumann, Norbert; Olsen, Klaus Juel; van Osta, Gonnie; Pocock, Stuart; Rockhold, Frank; Rossi, Andrea; Senn, Stephen; Stijnen, Theo; Vaeth, Michael; Wiklund, Stig Johan; Wolfram, Josephine | Journal Contribution | A1 |
| 105 | 2008 | Ensuring trial validity by data quality assurance and diversification of monitoring methods | Baigent, C.; Harrell, F.; BUYSE, Marc; Emberson, J.; Altman, D. | Proceedings Paper | C1 |
| 106 | 2008 | Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission. | BUYSE, Marc; Squifflet, Pierre; Rowe, Jacob M.; Whisnant, John K.; Bhagwat, Dileep; Allard, Stephane E.; Hellstrand, Kristoffer; Brune, Mats L. | Journal Contribution | M |
| 107 | 2008 | Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer | BURZYKOWSKI, Tomasz; BUYSE, Marc; Piccart-Gebhart, Martine J.; Sledge, George; Carmichael, James; Lueck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, Patrick | Journal Contribution | A1 |
| 108 | 2008 | The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; BUYSE, Marc | Journal Contribution | A1 |
| 109 | 2008 | Exploring and validating surrogate endpoints in colorectal cancer | BURZYKOWSKI, Tomasz; BUYSE, Marc; Yothers, Greg; Sakamoto, Junichi; Sargent, Dan | Journal Contribution | A1 |
| 110 | 2008 | Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments | PIEDBOIS, P.; BUYSE, Marc | Journal Contribution | A1 |
| 111 | 2008 | Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer | Piccart-Gebhart, Martine J.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sledge, George; Carmichael, James; Luck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, Patrick | Journal Contribution | A1 |
| 112 | 2008 | Individual- and trial-level surrogacy in colorectal cancer | BUYSE, Marc; BURZYKOWSKI, Tomasz; Michiels, Stefan; Carroll, Kevin | Journal Contribution | A1 |
| 113 | 2008 | Reformulating the hazard ratio to enhance communication with clinical investigators | BUYSE, Marc | Journal Contribution | A1 |
| 114 | 2007 | Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed! | Collette, Laurence; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 115 | 2007 | Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer | de Gramont, Aimery; BUYSE, Marc; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Cervantes, Andres; Figer, Arie; Lledo, Gerard; Flesch, Michel; Mineur, Laurent; Carola, Elisabeth; Etienne, Pierre-Luc; Rivera, Fernando; Chirivella, Isabel; Perez-Staub, Nathalie; Louvet, Christophe; André, Thierry; Tabah-Fisch, Isabelle; Tournigand, Christophe | Journal Contribution | A1 |
| 116 | 2007 | Progression-free survival is a surrogate for survival in advanced colorectal cancer | BUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, Kevin; Michiels, Stefan; Sargent, Daniel J.; Miller, Langdon L.; Elfring, Gary L.; Pignon, Jean-Pierre; Piedbois, Pascal | Journal Contribution | A1 |
| 117 | 2006 | Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial | Bogaerts, J.; Cardoso, F.; BUYSE, Marc; Braga, S.; Loi, S.; Harrison, J. A.; Bines, J.; Mook, S.; Decker, N.; Ravdin, P.; Therasse, P.; Rutgers, E.; van't Veer, L. J.; Piccart, M. | Journal Contribution | A1 |
| 118 | 2006 | Alternative clinical end points in rectal cancer—are we getting closer? | Glynne-Jones, R; Mawdsley, S; Pearce, T; BUYSE, Marc | Journal Contribution | A1 |
| 119 | 2006 | Analysis of oxaliplatin reintroduction in patients with advanced colorectal cancer (CRC) treated with FOLFOX4 or FOLFOX7 in the optimox study | BUYSE, Marc; Quinaux, E; CORTINAS ABRAHANTES, Jose; Tournigand, C; Cervantes, A; Figer, A; André, Thierry; Tabah-Fisch, I; De Gramont, A | Journal Contribution | M |
| 120 | 2006 | Current issues in adjuvant treatment of stage II colon cancer | André, Thierry; Sargent, D; Tabernero, J; O'Connell, M; BUYSE, Marc; Sobrero, A; Misset, J.L.; Boni, C; de Gramont, A | Journal Contribution | A1 |
| 121 | 2006 | Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validation | BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 122 | 2006 | A unifying approach for surrogate marker validation based on Prentice's criteria | ALONSO ABAD, Ariel; MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 123 | 2005 | Setting the scene | MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 124 | 2005 | The history of surrogate endpoint validation | MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Book Section | B2 |
Loading...
5
0
5
0
false